2012 European Nucleic Acid Testing Market: France, Germany, Italy, Spain, UK Emerging Opportunities and Business Expansion Strategies
Topics: Antisense & RNAi Technology
Regions: France, Germany, Italy, Spain, United Kingdom
|
2012 Global Nucleic Acid Testing Market Outlook: Growth Opportunities and Strategies
Topics: Antisense & RNAi Technology
Regions: Global
|
Global RNAi Market Analysis
Topics: Antisense & RNAi Technology
Regions: Global
|
RNA Interference Therapy in Oncology Drug Pipeline Update 2012
Topics: Antisense & RNAi Technology, Drug Discovery, Oncology/Hematology
|
Nucleic Acid Therapies in Oncology Drug Pipeline Update 2012
Topics: Antisense & RNAi Technology, Drug Discovery, Oncology/Hematology
|
Future Nucleic Acid Testing Market--New Product Development Opportunities and Business Expansion Strategies for Instrument and Reagent Suppliers
Topics: Antisense & RNAi Technology
|
Future Infectious Disease Nucleic Acid Testing
Topics: Antisense & RNAi Technology
|
Emerging Opportunities in Cancer Nucleic Acid Testing
Topics: Antisense & RNAi Technology
|
Future German Nucleic Acid Testing Market Outlook
Topics: Antisense & RNAi Technology
Regions: Germany
|
Future Italian Nucleic Acid Testing Market Outlook
Topics: Antisense & RNAi Technology
Regions: Italy
|
Future Spanish Nucleic Acid Testing Market Outlook
Topics: Antisense & RNAi Technology
Regions: Spain
|
Future US Nucleic Acid Testing Market Outlook
Topics: Antisense & RNAi Technology
Regions: United States
|
Leading Nucleic Acid testing Market Players
Topics: Antisense & RNAi Technology
|
Future French Nucleic Acid Testing Market Outlook
Topics: Antisense & RNAi Technology
Regions: France
|
Future Japanese Nucleic Acid Testing Market Outlook
Topics: Antisense & RNAi Technology
Regions: Japan
|
Future UK Nucleic Acid Testing Market Outlook
Topics: Antisense & RNAi Technology
Regions: United Kingdom
|
Cell-Based Assays: World Market Prospects 2012-2022
Topics: Antisense & RNAi Technology, Cell Culture
Regions: Global
|
Nucleic Acid Purification Life Science Dashboard™ Series 3
Topics: Antisense & RNAi Technology
|
Nucleic Acid Amplification Life Science Dashboard™ Series 3
Topics: Antisense & RNAi Technology
|
Conference Documentation: RNAi, miRNA & siRNA
Topics: Research & Development, Antisense & RNAi Technology
|
Lead Generation Strategies and Technologies in Drug Development - Emerging Techniques Such as Antisense Technology Will Allow Innovators to Minimize Costs
Topics: Antisense & RNAi Technology
|
Global Nucleic Acid Testing Market--New Product Development Opportunities and Business Expansion Strategies For Instrument and Reagent Suppliers
Topics: General Biotechnology, Antisense & RNAi Technology, General In Vitro Diagnostics
|
RNA interference (RNAi)
Topics: Antisense & RNAi Technology
Regions: Global
|
RNAi for Therapeutic Applications: Market Prospects 2011-2021
Topics: Antisense & RNAi Technology
|
Competitor Analysis RNA Therapeutics in Clinical Development
Topics: General Biotechnology, Antisense & RNAi Technology
|
RNA Therapeutics Pipeline Database: 1-Year Subscription
Topics: Antisense & RNAi Technology
|
Nucleic Acid Therapies in Oncology Drug Pipeline Update 2011
Topics: Antisense & RNAi Technology, Drug Discovery, Oncology/Hematology
|
RNAi Drug Delivery: Technologies and Global Markets
Topics: Antisense & RNAi Technology
|
Cell-Based Assays for Drug Discovery
Topics: Antisense & RNAi Technology, Drug Discovery
|
Advanced Drug Delivery Markets (Liposomes, Polymers and Monoclonal Antibodies)
Topics: Gene Therapy, Antibody Technologies, Antisense & RNAi Technology, Nanomedicine, Drug Delivery
|
Global Transfection Markets
Topics: Genomics, Antisense & RNAi Technology
Regions: Global
|
Top 10 Drug Discovery Technologies - Strategic Analysis And Global Forecasts
Topics: Proteomics, Research & Development, Antisense & RNAi Technology, Drug Discovery
|
RNAi: Product Usage and Brand Assessment
Topics: Antisense & RNAi Technology
|
Conference Documentation: RNAi, siRNA and miRNA (2010)
Topics: Antisense & RNAi Technology
|
Competitor Analysis: CMV Vaccines and Therapeutics
Topics: Antisense & RNAi Technology, Vaccines
|
Competitor Analysis: RSV Vaccines and Therapeutics
Topics: Antisense & RNAi Technology, Vaccines
|
Nucleic Acid Aptamers for Diagnostics and Therapeutics: Global Markets
Topics: Antibody Technologies, Antisense & RNAi Technology, Biomarkers, Biopharmaceuticals
|
Delivering RNAi-Based Therapeutics & Diagnostics: Challenges & Opportunities
Topics: Antisense & RNAi Technology
|
MDRNA, Inc. - SWOT Analysis
Topics: Biotechnology Company Reports, Antisense & RNAi Technology, M - Reports
|
The Future of RNAi Therapeutics: Drug Pipelines and Prospects
Topics: Antisense & RNAi Technology, Research & Development, Drug Discovery
|
European Nucleic Acid-based Amplification Reagents Markets for Clinical Applications
Topics: Genomics, Antisense & RNAi Technology, In Vitro Diagnostics, Molecular Assays
Regions: Europe
|
Realizing the Promise of Therapeutic RNAi: Emerging Strategies for RNAi Delivery
Topics: Antisense & RNAi Technology
|
RNAi Therapeutics 2008
Topics: Genomics, Antisense & RNAi Technology
|
Clinical Forecasting: A Novel Bayesian Tool for Predicting Phase III Outcomes
Topics: Informatics, Antisense & RNAi Technology
|
Outlook For Rnai, 2007: Sirna And Mirna In Biology, Diagnostics And Therapeutics
Topics: Antisense & RNAi Technology
|
High Content Analysis 2007
Topics: Antisense & RNAi Technology, Drug Discovery
|
RNAi/Nicro RNA Market Report
Topics: Antisense & RNAi Technology
|
Optimizing Synthetic RNAi: Perspectives from the Pharmaceutical and Biotech Industry
Topics: Research & Development, Antisense & RNAi Technology
|
Taking the Pharma Lead on RNAi: Merck Bets on Sirna
Topics: Antisense & RNAi Technology, M - Reports, S - Reports, Pharmaceuticals Company Reports
|
U.S. RNAi Markets
Topics: Antisense & RNAi Technology, Pharmaceuticals, Drug Delivery
Regions: United States
|
